Viewing Study NCT03119467

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 12:40 AM

Ignite Modification Date: 2026-01-05 @ 7:14 PM

Study NCT ID: NCT03119467

Status: TERMINATED

Last Update Posted: 2019-12-27

First Post: 2017-04-10

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

Sponsor: Rhizen Pharmaceuticals SA

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module